Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-12-18

AUTHORS

Koichi Kamei, Kenji Ishikura, Mayumi Sako, Shuichi Ito, Kandai Nozu, Kazumoto Iijima

ABSTRACT

Patients with steroid-resistant nephrotic syndrome (SRNS) who develop resistance to immunosuppressive agents, defined as refractory SRNS, have poor renal outcomes. Although the chimeric anti-CD20 monoclonal antibody rituximab has shown efficacy for frequently relapsing nephrotic syndrome and steroid-dependent nephrotic syndrome, its efficacy for refractory SRNS remains uncertain due to limited data. According to previous case reports, 50.4% of patients with refractory SRNS showed clinical improvements after rituximab treatment. Remission rates in patients with initial steroid resistance and late steroid resistance were 43.9 and 57.7%, respectively, and 41.5 and 63.6% in patients with focal segmental glomerulosclerosis and minor glomerular abnormalities, respectively. However, various factors (race, disease severity, number of rituximab doses, concomitant treatments, and observation period) differed among these observational studies and their consensus may also have been affected by potential publication bias. Rituximab monotherapy may have some degree of efficacy and lead to satisfactory outcomes in a subset of patients with refractory SRNS. However, administration of concomitant treatments during rituximab-mediated B cell depletion, such as methylprednisolone pulse therapy, daily oral prednisolone therapy, and immunosuppressive agents, may lead to better outcomes in these patients. Large-scale, multi-center prospective studies are needed to evaluate the efficacy and safety of such regimens. More... »

PAGES

17-24

References to SciGraph publications

  • 2018-05-17. Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment in NATURE COMMUNICATIONS
  • 2014-02-06. Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2008-05-20. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab in INTERNATIONAL UROLOGY AND NEPHROLOGY
  • 2013-05-23. Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2001-03. Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2018-07-07. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings in PEDIATRIC NEPHROLOGY
  • 2017-07-17. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials in PEDIATRIC NEPHROLOGY
  • 2007-11-01. Rituximab for refractory focal segmental glomerulosclerosis in PEDIATRIC NEPHROLOGY
  • 2015-06-09. Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2008-10-14. Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab in PEDIATRIC NEPHROLOGY
  • 2012-09-05. Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2010-01-27. Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2003-11-25. Enalapril dosage in steroid-resistant nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2017-10-11. Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances in PEDIATRIC NEPHROLOGY
  • 2009-12-23. Rituximab in refractory nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2009-12-22. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin in PEDIATRIC NEPHROLOGY
  • 2006-05-06. Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2014-03-16. Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2015-02-06. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy in CLINICAL AND EXPERIMENTAL NEPHROLOGY
  • 2017-01-14. Repeated administrations of rituximab along with steroids and immunosuppressive agents in refractory steroid-resistant nephrotic syndrome in INDIAN PEDIATRICS
  • 2011-01-31. Rituximab for refractory cases of childhood nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2004-08-18. Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2016-09-02. High incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide survey in Japan (JP-SHINE study) in CLINICAL AND EXPERIMENTAL NEPHROLOGY
  • 2006-11-05. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible in NATURE GENETICS
  • 2009-09-01. Fatal pulmonary fibrosis after rituximab administration in PEDIATRIC NEPHROLOGY
  • 2005-08-16. Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2009-08-28. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2018-02-09. Infusion reactions associated with rituximab treatment for childhood-onset complicated nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2009-08-01. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study in PEDIATRIC NEPHROLOGY
  • 2012-12-05. Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome? in PEDIATRIC NEPHROLOGY
  • 2012-10-10. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome in PEDIATRIC NEPHROLOGY
  • 2000-08. Treatment of FSGS with plasma exchange and immunadsorption in PEDIATRIC NEPHROLOGY
  • 2012-10-04. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis in PEDIATRIC NEPHROLOGY
  • 2009-12-19. Severe respiratory adverse events associated with rituximab infusion in PEDIATRIC NEPHROLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00467-018-4166-1

    DOI

    http://dx.doi.org/10.1007/s00467-018-4166-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1110754443

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30564879


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "B-Lymphocytes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Resistance", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Therapy, Combination", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucocorticoids", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunosuppressive Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphocyte Depletion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nephrotic Syndrome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Observational Studies as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pulse Therapy, Drug", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Recurrence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Remission Induction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rituximab", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.63906.3a", 
              "name": [
                "Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kamei", 
            "givenName": "Koichi", 
            "id": "sg:person.01316365041.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316365041.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.63906.3a", 
              "name": [
                "Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ishikura", 
            "givenName": "Kenji", 
            "id": "sg:person.01112735663.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112735663.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division for Clinical Trials, Department of Clinical Research, Center for Clinical Research and Development, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.63906.3a", 
              "name": [
                "Division for Clinical Trials, Department of Clinical Research, Center for Clinical Research and Development, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sako", 
            "givenName": "Mayumi", 
            "id": "sg:person.01032464245.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032464245.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pediatrics, Graduate School of Medicine, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Kanagawa, Japan", 
              "id": "http://www.grid.ac/institutes/grid.268441.d", 
              "name": [
                "Department of Pediatrics, Graduate School of Medicine, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Kanagawa, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ito", 
            "givenName": "Shuichi", 
            "id": "sg:person.012302533312.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012302533312.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Hyogo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.31432.37", 
              "name": [
                "Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Hyogo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nozu", 
            "givenName": "Kandai", 
            "id": "sg:person.0717317506.56", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717317506.56"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Hyogo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.31432.37", 
              "name": [
                "Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Hyogo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Iijima", 
            "givenName": "Kazumoto", 
            "id": "sg:person.01360637141.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360637141.54"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00467-009-1264-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014215541", 
              "https://doi.org/10.1007/s00467-009-1264-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-017-3746-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1090744154", 
              "https://doi.org/10.1007/s00467-017-3746-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-018-3994-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105406699", 
              "https://doi.org/10.1007/s00467-018-3994-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/pl00013420", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001860777", 
              "https://doi.org/10.1007/pl00013420"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-003-1314-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010752634", 
              "https://doi.org/10.1007/s00467-003-1314-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-013-2485-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039329871", 
              "https://doi.org/10.1007/s00467-013-2485-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-004-1584-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028397240", 
              "https://doi.org/10.1007/s00467-004-1584-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s004670000494", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028129758", 
              "https://doi.org/10.1007/s004670000494"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-009-1376-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043363246", 
              "https://doi.org/10.1007/s00467-009-1376-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-012-2361-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017924951", 
              "https://doi.org/10.1007/s00467-012-2361-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-011-1778-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051524286", 
              "https://doi.org/10.1007/s00467-011-1778-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10157-016-1319-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022803771", 
              "https://doi.org/10.1007/s10157-016-1319-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-007-0640-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035964062", 
              "https://doi.org/10.1007/s00467-007-0640-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-014-2800-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013865385", 
              "https://doi.org/10.1007/s00467-014-2800-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-012-2319-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023506176", 
              "https://doi.org/10.1007/s00467-012-2319-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng1918", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048825602", 
              "https://doi.org/10.1038/ng1918"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-009-1410-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040313036", 
              "https://doi.org/10.1007/s00467-009-1410-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-008-1030-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034882908", 
              "https://doi.org/10.1007/s00467-008-1030-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-015-3120-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024899507", 
              "https://doi.org/10.1007/s00467-015-3120-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-005-2013-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045340328", 
              "https://doi.org/10.1007/s00467-005-2013-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-009-1417-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020824519", 
              "https://doi.org/10.1007/s00467-009-1417-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11255-008-9393-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007937374", 
              "https://doi.org/10.1007/s11255-008-9393-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-012-2286-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009853115", 
              "https://doi.org/10.1007/s00467-012-2286-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-014-2765-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020955418", 
              "https://doi.org/10.1007/s00467-014-2765-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13312-017-0996-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003367239", 
              "https://doi.org/10.1007/s13312-017-0996-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-006-0096-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003470812", 
              "https://doi.org/10.1007/s00467-006-0096-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-009-1138-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048800371", 
              "https://doi.org/10.1007/s00467-009-1138-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41467-018-04193-w", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1103956834", 
              "https://doi.org/10.1038/s41467-018-04193-w"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-017-3793-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1092166342", 
              "https://doi.org/10.1007/s00467-017-3793-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-012-2314-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034124932", 
              "https://doi.org/10.1007/s00467-012-2314-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-009-1408-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019009454", 
              "https://doi.org/10.1007/s00467-009-1408-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-018-3900-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100938663", 
              "https://doi.org/10.1007/s00467-018-3900-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00467-009-1195-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028250994", 
              "https://doi.org/10.1007/s00467-009-1195-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10157-014-1030-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019458362", 
              "https://doi.org/10.1007/s10157-014-1030-x"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-12-18", 
        "datePublishedReg": "2018-12-18", 
        "description": "Patients with steroid-resistant nephrotic syndrome (SRNS) who develop resistance to immunosuppressive agents, defined as refractory SRNS, have poor renal outcomes. Although the chimeric anti-CD20 monoclonal antibody rituximab has shown efficacy for frequently relapsing nephrotic syndrome and steroid-dependent nephrotic syndrome, its efficacy for refractory SRNS remains uncertain due to limited data. According to previous case reports, 50.4% of patients with refractory SRNS showed clinical improvements after rituximab treatment. Remission rates in patients with initial steroid resistance and late steroid resistance were 43.9 and 57.7%, respectively, and 41.5 and 63.6% in patients with focal segmental glomerulosclerosis and minor glomerular abnormalities, respectively. However, various factors (race, disease severity, number of rituximab doses, concomitant treatments, and observation period) differed among these observational studies and their consensus may also have been affected by potential publication bias. Rituximab monotherapy may have some degree of efficacy and lead to satisfactory outcomes in a subset of patients with refractory SRNS. However, administration of concomitant treatments during rituximab-mediated B cell depletion, such as methylprednisolone pulse therapy, daily oral prednisolone therapy, and immunosuppressive agents, may lead to better outcomes in these patients. Large-scale, multi-center prospective studies are needed to evaluate the efficacy and safety of such regimens.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00467-018-4166-1", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.9337961", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.7853213", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1097267", 
            "issn": [
              "0931-041X", 
              "1432-198X"
            ], 
            "name": "Pediatric Nephrology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "35"
          }
        ], 
        "keywords": [
          "refractory steroid-resistant nephrotic syndrome", 
          "steroid-resistant nephrotic syndrome", 
          "nephrotic syndrome", 
          "steroid resistance", 
          "immunosuppressive agents", 
          "steroid-dependent nephrotic syndrome", 
          "multi-center prospective study", 
          "initial steroid resistance", 
          "late steroid resistance", 
          "methylprednisolone pulse therapy", 
          "oral prednisolone therapy", 
          "poor renal outcome", 
          "subset of patients", 
          "CD20 monoclonal antibody", 
          "minor glomerular abnormalities", 
          "previous case reports", 
          "focal segmental glomerulosclerosis", 
          "potential publication bias", 
          "degree of efficacy", 
          "pulse therapy", 
          "prednisolone therapy", 
          "renal outcomes", 
          "rituximab treatment", 
          "rituximab monotherapy", 
          "rituximab therapy", 
          "clinical improvement", 
          "remission rate", 
          "glomerular abnormalities", 
          "cell depletion", 
          "prospective study", 
          "such regimens", 
          "concomitant treatment", 
          "case report", 
          "segmental glomerulosclerosis", 
          "observational study", 
          "better outcomes", 
          "patients", 
          "satisfactory outcome", 
          "publication bias", 
          "syndrome", 
          "monoclonal antibodies", 
          "therapy", 
          "efficacy", 
          "limited data", 
          "outcomes", 
          "treatment", 
          "monotherapy", 
          "regimens", 
          "glomerulosclerosis", 
          "agents", 
          "abnormalities", 
          "administration", 
          "antibodies", 
          "children", 
          "study", 
          "resistance", 
          "report", 
          "safety", 
          "subset", 
          "depletion", 
          "factors", 
          "consensus", 
          "rate", 
          "improvement", 
          "data", 
          "lead", 
          "bias", 
          "degree"
        ], 
        "name": "Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children", 
        "pagination": "17-24", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1110754443"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00467-018-4166-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30564879"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00467-018-4166-1", 
          "https://app.dimensions.ai/details/publication/pub.1110754443"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-10T10:17", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_764.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00467-018-4166-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00467-018-4166-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00467-018-4166-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00467-018-4166-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00467-018-4166-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    373 TRIPLES      22 PREDICATES      143 URIs      101 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00467-018-4166-1 schema:about N0ecbe4d46fde414bacbd1e01831f3ba0
    2 N115e0e28f65c487fa6bf48670b442189
    3 N1f22ff7c1c374c049c770c475386a6df
    4 N360d0de5157d4d9dbba13ac4d179f214
    5 N653cd6279e2f4101be0d1f4c25486f62
    6 N7b354f965a1e473086eb15e1cbdafc48
    7 N98f3081152554d058222a32489191fa2
    8 Na011dd2fdb8a408f89c609ff84317460
    9 Nb7f407b9bab643b68e9cee3f9bd655e9
    10 Nbac7bd6f217748e3967992b7a4b9c4db
    11 Nd7b752e0b34046f8aa23e030d465a0f1
    12 Nddd517c85c834bcb95277e4554119fdd
    13 Nf0ce2ec4409443508af3bcd39a0490b2
    14 Nf720025871f54100834901f7c9e766fc
    15 Nff9f4eb27002448d8fd9fde38666a782
    16 anzsrc-for:11
    17 anzsrc-for:1103
    18 schema:author Nce5b0fbfd375461da84e28ee220e994b
    19 schema:citation sg:pub.10.1007/pl00013420
    20 sg:pub.10.1007/s00467-003-1314-y
    21 sg:pub.10.1007/s00467-004-1584-z
    22 sg:pub.10.1007/s00467-005-2013-7
    23 sg:pub.10.1007/s00467-006-0096-4
    24 sg:pub.10.1007/s00467-007-0640-x
    25 sg:pub.10.1007/s00467-008-1030-8
    26 sg:pub.10.1007/s00467-009-1138-5
    27 sg:pub.10.1007/s00467-009-1195-9
    28 sg:pub.10.1007/s00467-009-1264-0
    29 sg:pub.10.1007/s00467-009-1376-6
    30 sg:pub.10.1007/s00467-009-1408-2
    31 sg:pub.10.1007/s00467-009-1410-8
    32 sg:pub.10.1007/s00467-009-1417-1
    33 sg:pub.10.1007/s00467-011-1778-0
    34 sg:pub.10.1007/s00467-012-2286-6
    35 sg:pub.10.1007/s00467-012-2314-6
    36 sg:pub.10.1007/s00467-012-2319-1
    37 sg:pub.10.1007/s00467-012-2361-z
    38 sg:pub.10.1007/s00467-013-2485-9
    39 sg:pub.10.1007/s00467-014-2765-z
    40 sg:pub.10.1007/s00467-014-2800-0
    41 sg:pub.10.1007/s00467-015-3120-8
    42 sg:pub.10.1007/s00467-017-3746-9
    43 sg:pub.10.1007/s00467-017-3793-2
    44 sg:pub.10.1007/s00467-018-3900-z
    45 sg:pub.10.1007/s00467-018-3994-3
    46 sg:pub.10.1007/s004670000494
    47 sg:pub.10.1007/s10157-014-1030-x
    48 sg:pub.10.1007/s10157-016-1319-z
    49 sg:pub.10.1007/s11255-008-9393-0
    50 sg:pub.10.1007/s13312-017-0996-3
    51 sg:pub.10.1038/ng1918
    52 sg:pub.10.1038/s41467-018-04193-w
    53 schema:datePublished 2018-12-18
    54 schema:datePublishedReg 2018-12-18
    55 schema:description Patients with steroid-resistant nephrotic syndrome (SRNS) who develop resistance to immunosuppressive agents, defined as refractory SRNS, have poor renal outcomes. Although the chimeric anti-CD20 monoclonal antibody rituximab has shown efficacy for frequently relapsing nephrotic syndrome and steroid-dependent nephrotic syndrome, its efficacy for refractory SRNS remains uncertain due to limited data. According to previous case reports, 50.4% of patients with refractory SRNS showed clinical improvements after rituximab treatment. Remission rates in patients with initial steroid resistance and late steroid resistance were 43.9 and 57.7%, respectively, and 41.5 and 63.6% in patients with focal segmental glomerulosclerosis and minor glomerular abnormalities, respectively. However, various factors (race, disease severity, number of rituximab doses, concomitant treatments, and observation period) differed among these observational studies and their consensus may also have been affected by potential publication bias. Rituximab monotherapy may have some degree of efficacy and lead to satisfactory outcomes in a subset of patients with refractory SRNS. However, administration of concomitant treatments during rituximab-mediated B cell depletion, such as methylprednisolone pulse therapy, daily oral prednisolone therapy, and immunosuppressive agents, may lead to better outcomes in these patients. Large-scale, multi-center prospective studies are needed to evaluate the efficacy and safety of such regimens.
    56 schema:genre article
    57 schema:inLanguage en
    58 schema:isAccessibleForFree false
    59 schema:isPartOf N9366a5230f954fa7a07117867633e190
    60 Nfb3cf594d5454e9eb5c49ab692a04422
    61 sg:journal.1097267
    62 schema:keywords CD20 monoclonal antibody
    63 abnormalities
    64 administration
    65 agents
    66 antibodies
    67 better outcomes
    68 bias
    69 case report
    70 cell depletion
    71 children
    72 clinical improvement
    73 concomitant treatment
    74 consensus
    75 data
    76 degree
    77 degree of efficacy
    78 depletion
    79 efficacy
    80 factors
    81 focal segmental glomerulosclerosis
    82 glomerular abnormalities
    83 glomerulosclerosis
    84 immunosuppressive agents
    85 improvement
    86 initial steroid resistance
    87 late steroid resistance
    88 lead
    89 limited data
    90 methylprednisolone pulse therapy
    91 minor glomerular abnormalities
    92 monoclonal antibodies
    93 monotherapy
    94 multi-center prospective study
    95 nephrotic syndrome
    96 observational study
    97 oral prednisolone therapy
    98 outcomes
    99 patients
    100 poor renal outcome
    101 potential publication bias
    102 prednisolone therapy
    103 previous case reports
    104 prospective study
    105 publication bias
    106 pulse therapy
    107 rate
    108 refractory steroid-resistant nephrotic syndrome
    109 regimens
    110 remission rate
    111 renal outcomes
    112 report
    113 resistance
    114 rituximab monotherapy
    115 rituximab therapy
    116 rituximab treatment
    117 safety
    118 satisfactory outcome
    119 segmental glomerulosclerosis
    120 steroid resistance
    121 steroid-dependent nephrotic syndrome
    122 steroid-resistant nephrotic syndrome
    123 study
    124 subset
    125 subset of patients
    126 such regimens
    127 syndrome
    128 therapy
    129 treatment
    130 schema:name Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children
    131 schema:pagination 17-24
    132 schema:productId N72441e9bfc824349a77283bb27b51f16
    133 N901b7ca905f34b67bcbf6d905a4123fd
    134 Nc823a112c8894d25945391aee2033c39
    135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110754443
    136 https://doi.org/10.1007/s00467-018-4166-1
    137 schema:sdDatePublished 2022-05-10T10:17
    138 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    139 schema:sdPublisher N46e1cf00773a453493f83474b6e18adc
    140 schema:url https://doi.org/10.1007/s00467-018-4166-1
    141 sgo:license sg:explorer/license/
    142 sgo:sdDataset articles
    143 rdf:type schema:ScholarlyArticle
    144 N0ecbe4d46fde414bacbd1e01831f3ba0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Nephrotic Syndrome
    146 rdf:type schema:DefinedTerm
    147 N115e0e28f65c487fa6bf48670b442189 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Treatment Outcome
    149 rdf:type schema:DefinedTerm
    150 N13d22c3a63414416a8690d2b1d68a076 rdf:first sg:person.0717317506.56
    151 rdf:rest N2378b9e8ba244be8bee42511c43cfa88
    152 N1f22ff7c1c374c049c770c475386a6df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Drug Therapy, Combination
    154 rdf:type schema:DefinedTerm
    155 N2378b9e8ba244be8bee42511c43cfa88 rdf:first sg:person.01360637141.54
    156 rdf:rest rdf:nil
    157 N35b4717589994b97befb4f546d0a4614 rdf:first sg:person.012302533312.63
    158 rdf:rest N13d22c3a63414416a8690d2b1d68a076
    159 N360d0de5157d4d9dbba13ac4d179f214 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Humans
    161 rdf:type schema:DefinedTerm
    162 N46e1cf00773a453493f83474b6e18adc schema:name Springer Nature - SN SciGraph project
    163 rdf:type schema:Organization
    164 N653cd6279e2f4101be0d1f4c25486f62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Lymphocyte Depletion
    166 rdf:type schema:DefinedTerm
    167 N72441e9bfc824349a77283bb27b51f16 schema:name dimensions_id
    168 schema:value pub.1110754443
    169 rdf:type schema:PropertyValue
    170 N7b354f965a1e473086eb15e1cbdafc48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Pulse Therapy, Drug
    172 rdf:type schema:DefinedTerm
    173 N901b7ca905f34b67bcbf6d905a4123fd schema:name doi
    174 schema:value 10.1007/s00467-018-4166-1
    175 rdf:type schema:PropertyValue
    176 N9366a5230f954fa7a07117867633e190 schema:issueNumber 1
    177 rdf:type schema:PublicationIssue
    178 N98f3081152554d058222a32489191fa2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Glucocorticoids
    180 rdf:type schema:DefinedTerm
    181 N9be7cee31db749f6a24f376c1d586307 rdf:first sg:person.01112735663.13
    182 rdf:rest Nb2bd34c8142f47caa602788eb7851142
    183 Na011dd2fdb8a408f89c609ff84317460 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Immunosuppressive Agents
    185 rdf:type schema:DefinedTerm
    186 Nb2bd34c8142f47caa602788eb7851142 rdf:first sg:person.01032464245.22
    187 rdf:rest N35b4717589994b97befb4f546d0a4614
    188 Nb7f407b9bab643b68e9cee3f9bd655e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Drug Resistance
    190 rdf:type schema:DefinedTerm
    191 Nbac7bd6f217748e3967992b7a4b9c4db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Remission Induction
    193 rdf:type schema:DefinedTerm
    194 Nc823a112c8894d25945391aee2033c39 schema:name pubmed_id
    195 schema:value 30564879
    196 rdf:type schema:PropertyValue
    197 Nce5b0fbfd375461da84e28ee220e994b rdf:first sg:person.01316365041.17
    198 rdf:rest N9be7cee31db749f6a24f376c1d586307
    199 Nd7b752e0b34046f8aa23e030d465a0f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    200 schema:name B-Lymphocytes
    201 rdf:type schema:DefinedTerm
    202 Nddd517c85c834bcb95277e4554119fdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    203 schema:name Recurrence
    204 rdf:type schema:DefinedTerm
    205 Nf0ce2ec4409443508af3bcd39a0490b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    206 schema:name Rituximab
    207 rdf:type schema:DefinedTerm
    208 Nf720025871f54100834901f7c9e766fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    209 schema:name Observational Studies as Topic
    210 rdf:type schema:DefinedTerm
    211 Nfb3cf594d5454e9eb5c49ab692a04422 schema:volumeNumber 35
    212 rdf:type schema:PublicationVolume
    213 Nff9f4eb27002448d8fd9fde38666a782 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    214 schema:name Child
    215 rdf:type schema:DefinedTerm
    216 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    217 schema:name Medical and Health Sciences
    218 rdf:type schema:DefinedTerm
    219 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    220 schema:name Clinical Sciences
    221 rdf:type schema:DefinedTerm
    222 sg:grant.7853213 http://pending.schema.org/fundedItem sg:pub.10.1007/s00467-018-4166-1
    223 rdf:type schema:MonetaryGrant
    224 sg:grant.9337961 http://pending.schema.org/fundedItem sg:pub.10.1007/s00467-018-4166-1
    225 rdf:type schema:MonetaryGrant
    226 sg:journal.1097267 schema:issn 0931-041X
    227 1432-198X
    228 schema:name Pediatric Nephrology
    229 schema:publisher Springer Nature
    230 rdf:type schema:Periodical
    231 sg:person.01032464245.22 schema:affiliation grid-institutes:grid.63906.3a
    232 schema:familyName Sako
    233 schema:givenName Mayumi
    234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032464245.22
    235 rdf:type schema:Person
    236 sg:person.01112735663.13 schema:affiliation grid-institutes:grid.63906.3a
    237 schema:familyName Ishikura
    238 schema:givenName Kenji
    239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112735663.13
    240 rdf:type schema:Person
    241 sg:person.012302533312.63 schema:affiliation grid-institutes:grid.268441.d
    242 schema:familyName Ito
    243 schema:givenName Shuichi
    244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012302533312.63
    245 rdf:type schema:Person
    246 sg:person.01316365041.17 schema:affiliation grid-institutes:grid.63906.3a
    247 schema:familyName Kamei
    248 schema:givenName Koichi
    249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316365041.17
    250 rdf:type schema:Person
    251 sg:person.01360637141.54 schema:affiliation grid-institutes:grid.31432.37
    252 schema:familyName Iijima
    253 schema:givenName Kazumoto
    254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360637141.54
    255 rdf:type schema:Person
    256 sg:person.0717317506.56 schema:affiliation grid-institutes:grid.31432.37
    257 schema:familyName Nozu
    258 schema:givenName Kandai
    259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717317506.56
    260 rdf:type schema:Person
    261 sg:pub.10.1007/pl00013420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001860777
    262 https://doi.org/10.1007/pl00013420
    263 rdf:type schema:CreativeWork
    264 sg:pub.10.1007/s00467-003-1314-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1010752634
    265 https://doi.org/10.1007/s00467-003-1314-y
    266 rdf:type schema:CreativeWork
    267 sg:pub.10.1007/s00467-004-1584-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1028397240
    268 https://doi.org/10.1007/s00467-004-1584-z
    269 rdf:type schema:CreativeWork
    270 sg:pub.10.1007/s00467-005-2013-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045340328
    271 https://doi.org/10.1007/s00467-005-2013-7
    272 rdf:type schema:CreativeWork
    273 sg:pub.10.1007/s00467-006-0096-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003470812
    274 https://doi.org/10.1007/s00467-006-0096-4
    275 rdf:type schema:CreativeWork
    276 sg:pub.10.1007/s00467-007-0640-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1035964062
    277 https://doi.org/10.1007/s00467-007-0640-x
    278 rdf:type schema:CreativeWork
    279 sg:pub.10.1007/s00467-008-1030-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034882908
    280 https://doi.org/10.1007/s00467-008-1030-8
    281 rdf:type schema:CreativeWork
    282 sg:pub.10.1007/s00467-009-1138-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048800371
    283 https://doi.org/10.1007/s00467-009-1138-5
    284 rdf:type schema:CreativeWork
    285 sg:pub.10.1007/s00467-009-1195-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028250994
    286 https://doi.org/10.1007/s00467-009-1195-9
    287 rdf:type schema:CreativeWork
    288 sg:pub.10.1007/s00467-009-1264-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014215541
    289 https://doi.org/10.1007/s00467-009-1264-0
    290 rdf:type schema:CreativeWork
    291 sg:pub.10.1007/s00467-009-1376-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043363246
    292 https://doi.org/10.1007/s00467-009-1376-6
    293 rdf:type schema:CreativeWork
    294 sg:pub.10.1007/s00467-009-1408-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019009454
    295 https://doi.org/10.1007/s00467-009-1408-2
    296 rdf:type schema:CreativeWork
    297 sg:pub.10.1007/s00467-009-1410-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040313036
    298 https://doi.org/10.1007/s00467-009-1410-8
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1007/s00467-009-1417-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020824519
    301 https://doi.org/10.1007/s00467-009-1417-1
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1007/s00467-011-1778-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051524286
    304 https://doi.org/10.1007/s00467-011-1778-0
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1007/s00467-012-2286-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009853115
    307 https://doi.org/10.1007/s00467-012-2286-6
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1007/s00467-012-2314-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034124932
    310 https://doi.org/10.1007/s00467-012-2314-6
    311 rdf:type schema:CreativeWork
    312 sg:pub.10.1007/s00467-012-2319-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023506176
    313 https://doi.org/10.1007/s00467-012-2319-1
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1007/s00467-012-2361-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1017924951
    316 https://doi.org/10.1007/s00467-012-2361-z
    317 rdf:type schema:CreativeWork
    318 sg:pub.10.1007/s00467-013-2485-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039329871
    319 https://doi.org/10.1007/s00467-013-2485-9
    320 rdf:type schema:CreativeWork
    321 sg:pub.10.1007/s00467-014-2765-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1020955418
    322 https://doi.org/10.1007/s00467-014-2765-z
    323 rdf:type schema:CreativeWork
    324 sg:pub.10.1007/s00467-014-2800-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013865385
    325 https://doi.org/10.1007/s00467-014-2800-0
    326 rdf:type schema:CreativeWork
    327 sg:pub.10.1007/s00467-015-3120-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024899507
    328 https://doi.org/10.1007/s00467-015-3120-8
    329 rdf:type schema:CreativeWork
    330 sg:pub.10.1007/s00467-017-3746-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090744154
    331 https://doi.org/10.1007/s00467-017-3746-9
    332 rdf:type schema:CreativeWork
    333 sg:pub.10.1007/s00467-017-3793-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092166342
    334 https://doi.org/10.1007/s00467-017-3793-2
    335 rdf:type schema:CreativeWork
    336 sg:pub.10.1007/s00467-018-3900-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1100938663
    337 https://doi.org/10.1007/s00467-018-3900-z
    338 rdf:type schema:CreativeWork
    339 sg:pub.10.1007/s00467-018-3994-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105406699
    340 https://doi.org/10.1007/s00467-018-3994-3
    341 rdf:type schema:CreativeWork
    342 sg:pub.10.1007/s004670000494 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028129758
    343 https://doi.org/10.1007/s004670000494
    344 rdf:type schema:CreativeWork
    345 sg:pub.10.1007/s10157-014-1030-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1019458362
    346 https://doi.org/10.1007/s10157-014-1030-x
    347 rdf:type schema:CreativeWork
    348 sg:pub.10.1007/s10157-016-1319-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1022803771
    349 https://doi.org/10.1007/s10157-016-1319-z
    350 rdf:type schema:CreativeWork
    351 sg:pub.10.1007/s11255-008-9393-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007937374
    352 https://doi.org/10.1007/s11255-008-9393-0
    353 rdf:type schema:CreativeWork
    354 sg:pub.10.1007/s13312-017-0996-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003367239
    355 https://doi.org/10.1007/s13312-017-0996-3
    356 rdf:type schema:CreativeWork
    357 sg:pub.10.1038/ng1918 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048825602
    358 https://doi.org/10.1038/ng1918
    359 rdf:type schema:CreativeWork
    360 sg:pub.10.1038/s41467-018-04193-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1103956834
    361 https://doi.org/10.1038/s41467-018-04193-w
    362 rdf:type schema:CreativeWork
    363 grid-institutes:grid.268441.d schema:alternateName Department of Pediatrics, Graduate School of Medicine, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Kanagawa, Japan
    364 schema:name Department of Pediatrics, Graduate School of Medicine, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, 236-0004, Yokohama, Kanagawa, Japan
    365 rdf:type schema:Organization
    366 grid-institutes:grid.31432.37 schema:alternateName Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Hyogo, Japan
    367 schema:name Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Hyogo, Japan
    368 rdf:type schema:Organization
    369 grid-institutes:grid.63906.3a schema:alternateName Division for Clinical Trials, Department of Clinical Research, Center for Clinical Research and Development, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan
    370 Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan
    371 schema:name Division for Clinical Trials, Department of Clinical Research, Center for Clinical Research and Development, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan
    372 Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, 157-8535, Tokyo, Japan
    373 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...